Connect with us

Technology

Qure.ai’s Clinical Decision Support System Aira Among World’s First to Win Class IIb CE Certification

Published

3 hours ago

on

Built for frontline primary care in emerging economies, Aira is the first AI-powered clinical decision support system (CDSS) to combine documentation, workflow automation and analysis of patient EHR data with clinical decision-making under a single CE mark.

MUMBAI, India and NEW YORK, Sept. 18, 2026 /PRNewswire/ — Qure.ai, a global leader in AI-powered early diagnosis and care orchestration, today announced that Aira has received Class IIb CE certification under the EU Medical Device Regulation (MDR) for its clinical decision support system (CDSS). This milestone comes a year after Aira’s launch and extends Qure.ai’s decade of experience in regulated medical AI — spanning TB, lung cancer and other non-communicable diseases — to AI-powered clinical decision support.

Launched at the World Health Assembly in 2025, Aira is built to address three persistent challenges in primary care: workforce shortages, inconsistent adherence to clinical guidelines, and the administrative burden that takes health workers away from patients. The platform integrates with existing health systems as an AI layer on top, turning consultations and paper records into a digital care trail, equipping health workers with patient history and national guideline-based recommendations, and maintaining patient contact between visits. Built for local languages, existing digital devices and unreliable connectivity, Aira makes digitization part of care delivery rather than an additional task for overstretched frontline workers.

By automating routine documentation and follow-up, and delivering current clinical guidance into everyday care, Aira helps stretched health workers maximize their time to deliver higher quality care. The ambition is to make consistent, connected primary care possible even where workforce capacity and digitization remain limited.

“The quality of primary care a person receives should not be decided by their postcode,” said Prashant Warier, Co-founder and CEO of Qure.ai. “But a health worker cannot give a patient their full attention while filling registers, searching for guidance and chasing missed appointments. We built Aira to take on that work. Class IIb certification is an important milestone because it validates our clinical decision support within one of the world’s most rigorous medical device regulatory frameworks. The bigger ambition is to put dependable clinical intelligence within reach of the people delivering care where resources are stretched furthest.”

Under the EU Medical Device Regulation, Class IIb classification reflects one of the EU’s highest levels of regulatory scrutiny for software supporting decisions where accuracy and reliability are critical to patient outcomes. Aira’s clinical decision support has been certified under this framework, giving health ministries, providers and funders an independently assessed foundation for evaluation and procurement, subject to applicable local rules.

In its first year, Aira has scaled to ten live pilot sites reaching thousands of patients and care seekers across wide-ranging last-mile and urban contexts in Nigeria, Kenya, Mozambique, Solomon Islands and Bangladesh. In Nigeria, it supports ART-center (Anti-Retroviral Therapy) health workers with structured data capture and guideline-based decision support, delivered with the Catholic Caritas Foundation of Nigeria in Enugu and Ebonyi, and the Adamawa State HIV/AIDS and STI Control Program.

In Kenya, Aira is deployed with local implementation partners and Ministry of Health departments. In Mozambique, it is integrated into AlôVida, the national platform run by the Ministry of Health (MISAU), with VillageReach as implementing partner and Qure.ai providing the technology, supporting pandemic preparedness through a Gates Foundation initiative. In the Solomon Islands, Aira has digitized paper-based health reporting in support of WHO’s Western Pacific Regional Office national reporting work. In Bangladesh, it is being deployed with the support of Endless Health.

In a Kenya outreach program, Aira cut time spent on protocol-driven documentation by 32% while ensuring a 98% completion rate in documentation tasks. Within primary HIV care facilities in Nigeria, the clinical-to-administrative time ratio improved by 67% in favor of patient-facing time, alongside a 23% reduction in administrative time.

Aira also supports continuous patient care between visits. In Nigeria, automated calls in Hausa and English remind patients about upcoming appointments and reconnect with patients who have missed scheduled care while also helping ensure consistent adherence to clinical protocols across teams.

Qure.ai’s broader AI portfolio is deployed across 105+ countries, with 26+ FDA-cleared findings and CE marking for 60+ indications. The company is now working with ministries of health and institutional funders on population-scale deployments of Aira over existing national systems, with the aim of building a larger evidence base for AI-supported care and patient outcomes.

Qure.ai believes this is the beginning of a broader shift: AI that doesn’t just support diagnosis but strengthens the entire primary care system around it, turning every health worker interaction into an opportunity for guideline-driven, data-backed care. At population scale, this is how the global health community closes the primary care gap for the billions still underserved.

To know more about Aira: https://www.qure.ai/aira

About Qure.ai

Qure.ai is a global AI company innovating diagnostic solutions in healthcare for early detection and care management. Qure’s solutions power early diagnosis in lung cancer, neurology and infectious disease to support clinicians and propel developments in the pharmaceutical and medical device industries. The company empowers healthcare workers or health systems by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life. Qure.ai has deployments in over 107 countries, with regional offices in New York, London and Mumbai. It is a TIME100 Most Influential Company 2025. 

 

View original content:https://www.prnewswire.co.uk/news-releases/qureais-clinical-decision-support-system-aira-among-worlds-first-to-win-class-iib-ce-certification-302883094.html

Related Topics:
Continue Reading

Technology

Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock

Published

35 minutes ago

on

September 18, 2026

By

Hyperscale Data Also Declares Monthly Cash Dividend of $0.20833 per Share of 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock

LAS VEGAS, Sept. 18, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), today announced that its Board of Directors (the “Board”) has declared a monthly cash dividend of $0.2708333 per share of the Company’s outstanding 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock.

Link to NYSE quote for the Company’s 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock:  https://www.nyse.com/quote/XASE:GPUSpD

The Company also announced today that the Board has declared a monthly cash dividend of $0.20833 per share of the Company’s outstanding 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock.

The record date for both dividends is September 30, 2026, and the payment date is Tuesday, October 13, 2026.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors, and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data’s wholly owned subsidiaries, Ault Capital Group, Inc. (“ACG”), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8- K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-declares-monthly-cash-dividend-of-0-2708333-per-share-of-13-00-series-d-cumulative-redeemable-perpetual-preferred-stock-302881479.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

BAIC FOTON Showcases Full Product Strength at IAA TRANSPORTATION 2026

Published

35 minutes ago

on

September 18, 2026

By

HANNOVER, Germany, Sept. 18, 2026 /PRNewswire/ — BAIC FOTON presented seven vehicles and six core components at IAA TRANSPORTATION 2026, covering long-haul freight, urban logistics, public transport and specialist operations. The Hall 21 display showed the company combining electrified powertrains, intelligent vehicle systems and in-house component development to address different global commercial transport requirements.

CAVAN BEACON Leads the Technology Display

Leading the presentation was the CAVAN BEACON, a battery-electric heavy-duty truck developed on a dedicated platform that also supports gaseous and liquid hydrogen configurations. Its 800 V electrical system works with megawatt charging technology to add approximately 100 km of range in six minutes under specified conditions. A “1+3+2” VDCU architecture integrates seven cameras, five radars and one LiDAR sensor, supporting 22 driver-assistance functions across 114 operating scenarios. Together, these technologies aim to improve charging efficiency, vehicle control, driver comfort and operational safety in long-haul applications.

Products for Diverse Operating Scenarios

The wider lineup extended those capabilities across additional vehicle categories. The GALAXUS R9 PHEV pairs a hybrid-specific engine with a transmission offering up to 99.8 percent efficiency, supported by more than 20 control modules and over 80 vehicle-control strategies. For urban logistics, the battery-electric DAYSTAR offers a maximum stated range of 600 km, while the CAVAN C1 is designed for last-mile distribution. The eGALAXUS D3 supports frequent stop-and-go sanitation work, and the eAURORA bus offers charging at up to 400 kW. For customers requiring greater versatility, the TUNLAND V9 PHEV pickup delivers 350 kW of combined power, 800 Nm of torque and up to 1,000 km of combined range. Batteries, electric drive axles, electronic controls and megawatt charging equipment completed the display, demonstrating how BAIC FOTON develops vehicles and supporting technologies as an integrated system.

International Validation Supports Further Expansion

The exhibition also reflected BAIC FOTON’s progress in overseas markets. The CAVAN C1 and eAURORA have received EU whole-vehicle type approval, while the GALAXUS R9 completed testing in Spain before becoming the company’s 13 millionth vehicle delivered worldwide. With products now present in more than 140 countries and regions, BAIC FOTON is continuing to adapt its portfolio for local regulations, operating conditions and customer requirements as commercial transport moves toward lower-emission and more connected operations.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/baic-foton-showcases-full-product-strength-at-iaa-transportation-2026-302883184.html

SOURCE BAIC FOTON

Continue Reading

Technology

Xryma Plc Reports Steady H1 2026 Results While Positioning the Group for Its Next Phase of Growth

Published

2 hours ago

on

September 18, 2026

By

NICOSIA, Cyprus, Sept. 18, 2026 /PRNewswire/ — Xryma Plc (“Group”, “Xryma”), a banktech group providing regulated cross-border open banking, international transactional banking and real-time EU and UK payment services, whilst also independently offering banking software and technology to third party banks and financial institutions, today announced its audited H1 2026 financial results for the six months ended 30 June 2026.

“The first half of 2026 remained firmly within the strategic investment period we outlined to shareholders. We made a conscious decision to prioritise the infrastructure and new opportunities required for Xryma’s next phase of growth, accepting the near-term impact this would have on Client Revenue and profitability,” said Ajay Treon, Group Chief Financial Officer & Executive Director, Xryma Plc.

“Importantly, that investment is now translating into delivery. We completed our Eurosystem T2 integration in June, continued to progress TIPS, PaidBy® and XrymaCoin, while Technology Services (as defined in the Prospectus) continued its strong growth, with revenue increasing 77%. Our SaaS and Banking Platform activities provide stable recurring income alongside higher-value consulting, bespoke development and customisation revenues.

We have achieved this while remaining profitable and maintaining a strong financial position, ending H1 2026 with €59.4 million of net assets and €50.9 million of cash. As the principal build phase of our strategic investment programme approaches completion, our focus is now shifting to activation, commercialisation and growth. We expect to see the first signs of that commercial momentum in Q4 2026, with the benefits of the investments we have made beginning to materialise from 2027 through revenue growth and operating leverage.”

H1 2026 Highlights

Strategic investment programme nearing completion, with the Group’s focus progressively shifting from investment and build to activation, commercialisation and growth.Client Revenue of €16.9 million, compared with €27.7 million in H1 2025, reflecting the anticipated near-term impact of prioritising strategic investment, and deferring certain complementary enhancements to existing products and services.Technology Services revenue increased 77% to €1.65 million, compared with €0.93 million in H1 2025, supported by recurring SaaS and Banking Platform income alongside higher-value consulting, bespoke development and customisation.The Group remained profitable throughout the investment period, reporting profit after tax of €0.03 million, compared with €12.3 million in H1 2025.Strong financial position maintained, with net assets of €59.4 million and cash and cash equivalents of €50.9 million at 30 June 2026, while continuing to meet applicable regulatory capital requirements.Major strategic milestones delivered, including completion of direct Eurosystem T2 integration in June 2026 following successful notification of participation in October 2025, together with continued progress across TIPS, PaidBy® Mastercard and XrymaCoin.Active capital allocation continued, including the early termination and repayment of the restructured NSX loan facilities and increased investment in BeEmotion AI, alongside progress towards completing the KYC initiative with BeEmotion.Commercial momentum expected to be regained in Q4 2026, with the benefits of the strategic investment programme expected to begin materialising from 2027 through revenue growth and operating leverage.

Nikogiannis Karantzis, Group Managing Director & Chief Executive Officer, Xryma Plc said: “Our commitment to delivering outstanding products and services to our existing customers remains unwavering. We are dedicated to expanding our customer base and increasing revenues in H2 2026, following the deep infrastructure upgrades of 2025 and H1 2026. Whilst this upgrade programme has impacted our short-term performance, we are of the belief that Xryma will be better positioned to grow revenues in the mid to long-term, with better margins due to our unique positioning in the market.

We are also pleased to have announced that the company’s Prospectus was approved by its competent authority, the Cyprus Securities and Exchange Commission (CySEC) on the 14th of July 2026. We will continue to advance our stock exchange listing plans, thus providing liquidity to our existing shareholders, broadening access to capital markets and supporting the Group’s long-term growth ambitions.”

View Xryma Plc H1 2026 – Interim Six Month Results

About Xryma Plc

Xryma Plc is a regulated European bank-tech group that develops banking technology via its Probanx® subsidiary and operates digital payment services underpinned by direct central-bank settlement. Xryma is one of the first non-bank participants authorised to connect directly to the Eurosystem’s T2 RTGS and TIPS platforms. The company holds Electronic Money Institution (EMI) authorisations in both the EU and the UK and offers multi-currency corporate accounts. Its open-banking service, PaidBy®, delivers one of the world’s first cross-border, account-to-account, dynamic-currency-converting service for merchants, with instant local payments and next-business-day settlement in major and exotic currencies. Xryma is also the issuer of the upcoming electronic-money token XrymaCoin (XREUR).

Media Contact: Media@xryma.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/xryma-plc-reports-steady-h1-2026-results-while-positioning-the-group-for-its-next-phase-of-growth-302883120.html

SOURCE Xryma Plc

Continue Reading

Trending